malariacontrol.net Molecules | Sunset Lake Software Molecules is an application for the iPhone, iPod touch, and now iPad that allows you to view three-dimensional renderings of molecules and manipulate them using your fingers. You can rotate the molecules by moving your finger across the display, zoom in or out by using two-finger pinch gestures, or pan the molecule by moving two fingers across the screen at once. The combination of the iPhone, iPod touch, and iPad's unique multitouch input system and the built-in OpenGL ES 3-D graphics capabilities enable you to feel like you are manipulating the molecules themselves with your fingers. New molecules can be downloaded from the RCSB Protein Data Bank ( an international repository of biological molecules and their 3-D structures, or NCBI's PubChem, a public database of compounds. Molecules can be downloaded directly to your handheld device and stored there for later viewing. Molecules is free and its source code is available under the BSD license. Related posts
FiND@Home 2,906,889 tasks After the huge crash of the database, everything is fixed and ready to go. 2,906,889 more WUs! Edit: The transitioner need to catch up 23 Feb 2015, 16:42:17 UTC · Comment Project down this weekend I stopped the BOINC server. 8,310,176 WUs New batch! I increased the predicted running time for this batch. New WUs I just put 3 192 552 more WU! Have fun :) 13 Jan 2015, 11:23:52 UTC · Comment FightMalaria@Home data now available online Hi all volunteers, We have made a results website for easy access to the data we generated using the FM@H BOINC server. We're still doing the last repeat calculations for the remaining MMV19k and other datasets, the results of which we'll add to this website. I had hoped to get the publication out prior to releasing this 'raw' data, but this is taking longer than I'd hoped. Thanks again for your generous contributions to this project.
Generic vs Brand Name Medicines Generic name. Each medicine has an approved name called the generic name. A group of medicines that have similar actions often have similar-sounding generic names. The brand name is usually written most clearly on any packaging. The colour, size, shape, etc, of brands of the same medicine may vary depending on which company makes it. Some tablets or pills contain a combination of medicines. Doctors are encouraged to prescribe by using the generic name. The generic name is the one doctors are trained to use. A few medicines, however, are always prescribed by the specific brand. In the UK there are strict quality controls before a product licence is granted for brand (trade) named or generic versions of medicines. Check with your pharmacist if in doubt about the use of a medicine.
Ebola: The race for drugs and vaccines 11 February 2015Last updated at 10:44 ET Many organisations are working together to find suitable medicines The race is on to find ways to prevent and cure the Ebola virus - a disease that has killed more than 8,000 people in Sierra Leone, Guinea and Liberia. There are no proven treatments for Ebola or vaccines to prevent individuals becoming infected. However, progress is now being made on an unprecedented scale. Trials, which would normally take years and decades, are being fast-tracked on a timescale of weeks and months. Vaccines in development The aim is to use the lowest dose of vaccine possible that provides protection Vaccines train the immune systems of healthy people to fight off any future infection. Three potential immunisations are frontrunners, having been rushed from promising animal studies into human trials. And the third to enter human testing is made by Johnson and Johnson together with the company Bavarian Nordic. The real test comes next as trials start in Liberia.
Nanobots Could Remove Arterial Plaque The concept of tiny robots swimming through the bloodstream has existed for decades. The idea was made famous by the 1966 film Fantastic Voyage, in which a human team is shrunk to fit into a submarine measuring one micrometer to dissolve a patient’s blood clot. Nanotechnology expert Chris Phoenix even floated the idea of replacing blood with a network of robots known as the vasculoid. They system could hypothetically replicate the function of blood while staving off infections and cancer, and eliminating vascular diseases such as atherosclerosis. Less far-fetched is a Ukrainian research project that proposes using nanobots to attack atherosclerotic plaque. A nanotechnology-based system could overcome these hurdles by making the procedure non-invasive. The technology leverages work from Eric Drexler, PhD, who came up for the word nanotechnology in the 1980s. The researchers estimate that the technology is at least a decade away from commercialization.
Marijuana On June 6, 2005, the Supreme Court ruled that the federal government has the power to prohibit and prosecute the possession and use of marijuana for medical purposes — even in the 20 states (Alaska, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Massachusetts, Michigan, Montana, Nevada, New Hampshire, New Jersey, New Mexico, Oregon, Rhode Island, Vermont and Washington) and Washington, D.C., where it is currently legal. The decision overturned a 2003 ruling by a federal appeals court that shielded California's Compassionate Use Act, the medical-marijuana initiative adopted by the state's voters nine years ago, from federal drug enforcement. The appeals court had held that Congress lacked constitutional authority to regulate the noncommercial cultivation and use of marijuana that did not cross state lines.
The Placebo Effect A placebo (or dummy pill) is an inert substance, typically a tablet, capsule or other dose form that does not contain an active drug ingredient. For example, placebo pills or liquids may contain starch, sugar, or saline. Physical placebo, or “sham” treatments have also been used, such as inactive acupuncture devices. Placebos are often used in clinical trials as an inactive control so that researchers can better evaluate the true overall effect of the experimental drug treatment under study. Conducting a double-blind, placebo-controlled clinical trial helps to eliminate any bias that might occur due to knowledge of who receives which treatments. What is the placebo effect? Research has shown that a placebo treatment can have a positive therapeutic effect in a patient, even though the pill or treatment is not active. A nocebo effect is the opposite of the placebo effect - a negative psychological effect of a treatment with no pharmacologic activity. References 1. 2. 3. 4.
PNIRS - Home Ted Kaptchuk of Harvard Medical School studies placebos | Harvard Magazine Jan-Feb 2013 Two weeks into Ted Kaptchuk’s first randomized clinical drug trial, nearly a third of his 270 subjects complained of awful side effects. All the patients had joined the study hoping to alleviate severe arm pain: carpal tunnel, tendinitis, chronic pain in the elbow, shoulder, wrist. In one part of the study, half the subjects received pain-reducing pills; the others were offered acupuncture treatments. And in both cases, people began to call in, saying they couldn’t get out of bed. The pills were making them sluggish, the needles caused swelling and redness; some patients’ pain ballooned to nightmarish levels. “The side effects were simply amazing,” Kaptchuk explains; curiously, they were exactly what patients had been warned their treatment might produce. Although Kaptchuk, an associate professor of medicine, has spent his career studying these mysterious human reactions, he doesn’t argue that you can simply “think yourself better.” To Dr.
Nocebo - Placebo In the strictest sense, a nocebo response is where a drug-trial's subject's symptoms are worsened by the administration of an inert, sham, or dummy (simulator) treatment, called a placebo. In its original application, nocebo had a very specific meaning in the medical domains of pharmacology, and nosology, and aetiology. It was a subject-oriented adjective that was used to label the harmful, injurious, unpleasant or undesirable reactions (or responses) that a subject manifested - thus, nocebo reactions (or nocebo responses) - as a consequence of the administration of an inert, dummy drug, in cases where these responses had not been chemically generated, and were entirely due to the subject's pessimistic belief and expectation that the inert drug in question would produce harmful, injurious, unpleasant or undesirable consequences.
Can dogs smell cancer? By Dina Zaphiris Yes, dogs can smell cancer. They can even smell it “in situ”, or at stage zero. Let’s take a closer look at why dogs are even interested in smelling cancer in the first place. Dogs can smell in parts per trillion. Training dogs to smell cancer is done in the same way that bomb and narcotics dogs are trained, pairing the target odor with a high value reward. Psychosomatism: Psychosomatism It's what I named this blog, and for a specific reason. Psychosomatism is a condition in which the person believes themselves to be inflicted with certain diseases; the diseases are not real, their symptoms are all (or mostly all, some may be present but overexaggerated) made up; it's a sort of paranoia where every single rumor of the existence of something sets off the person's fear. It's basically a big head game with yourself, having this; mind over matter and such. Now, am I psychosomatic? No.
Psychosomatic medicine Psychosomatic medicine is an interdisciplinary medical field studying the relationships of social, psychological, and behavioral factors on bodily processes and quality of life in humans and animals. The academic forebear of the modern field of behavioral medicine and a part of the practice of consultation-liaison psychiatry, psychosomatic medicine integrates interdisciplinary evaluation and management involving diverse specialties including psychiatry, psychology, neurology, internal medicine, surgery, allergy, dermatology and psychoneuroimmunology. Clinical situations where mental processes act as a major factor affecting medical outcomes are areas where psychosomatic medicine has competence.[1] History of psychosomatics[edit] In the medieval Islamic world the Persian psychologist-physicians Ahmed ibn Sahl al-Balkhi (d. 934) and Haly Abbas (d. 994) developed an early understanding of illness that was due to the interaction of the mind and the body. Psychosomatic disorders[edit]